Neurologic Complications in Spinal Deformity Surgery - Extension
NCT ID: NCT02949245
Last Updated: 2020-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2017-08-17
2019-12-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Regression analyses were used to evaluate the association between patient demographics, co-morbidities, treatment history, spinal deformity characteristics, surgical characteristics, non-neurologic complications and pre-surgical status to occurrence of a neurologic deficit after surgery.
All enrolled Scoli-RISK-1 participants will be re-consented and asked to return for a 5 year FU visit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mini-invasive Spine Surgery for Neuromuscolar Scoliosis
NCT06367933
Surgical Treatment for Spinal Cord Injury
NCT01674764
The Idiopathic Scoliosis and Its Treatment (Orthopaedic and Surgery): Effect of the Severity, the Orthosis and the Arthrodesis on the Gait
NCT00842218
Incomplete Cervical SCI Without Instability
NCT05653206
Spinal Cord Stimulation Assisted by Motor Rehabilitation Training for Restoring Motor Function After Spinal Cord Injury
NCT05926843
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Given this lack of information, there is a need to determine the true incidence of complications using a prospective multi-center design. There is a need to identify neurologic deficits in a more systematic fashion to include spinal cord, cauda equina and nerve root deficits as well as radiculopathies. The risk factors associated with the occurrence of a complication, especially a neurologic complication, also needs to be more fully elucidated. This is increasingly relevant, as newer surgical techniques allow for more aggressive correction of the spinal deformity that may put the spinal cord and nerve roots at increased risk. Valid data on the incidence and types of neurologic deficits is also needed in order to study newer drugs that are available that may mitigate this risk.
The primary objectives of this study are: (i) to establish the incidence of neurologic deficit in "high risk" adult patients undergoing correction of their spinal deformity of adult spinal deformity and (ii) to identify characteristics associated with increased risk of neurologic complications. Secondary objectives include (i) to determine the incidence of all complications related to surgical correction of "high risk" adult spinal deformity; (ii) to determine the short-term clinical outcomes in patients undergoing correction of their spinal deformity and (iii).to determine amount of radiographic and clinical correction of deformity
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Groups/Cohorts
Surgical treatment
This observational study is examining the outcomes of standard surgical treatments for adult spinal deformity.
Interventions
Procedure/Surgery: Routinely performed surgical correction of spinal deformity
Routinely performed surgical correction of spinal deformity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interventions
Procedure/Surgery: Routinely performed surgical correction of spinal deformity
Routinely performed surgical correction of spinal deformity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent for extended study
Exclusion Criteria
* Subjects which by law are not eligible to participate any longer in clinical trials
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Scoliosis Research Society
OTHER
AO Foundation, AO Spine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lawrence Lenke, MD
Role: PRINCIPAL_INVESTIGATOR
Scoliosis Research Society
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California
San Francisco, California, United States
Johns Hopkins University
Baltimore, Maryland, United States
Department of Orthopaedic Surgery, Washington University School of Medicine
St Louis, Missouri, United States
NYU School of Medicine
New York, New York, United States
University of Virginia
Charlottesville, Virginia, United States
University of Toronto Hospital
Toronto, Ontario, Canada
University of Hong Kong
Hong Kong, , China
Nanjing Drum Tower Hospital
Nanjing, , China
Hamamatsu University School of Medicine
Hamamatsu, , Japan
Hospital Universitari Vall D'Hebron
Barcelona, , Spain
University Hospital Nottingham, NHS Trust
Nottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Scoli-RISK-1 extension
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.